⌘K

Login Start Free

Home/Filings/4/0000875320-26-000004

4//SEC Filing

Tatsis Ourania 4

Accession 0000875320-26-000004

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 4:05 PM ET

Size

4.7 KB

Accession

0000875320-26-000004

Insider Transaction Report

Form 4

Period: 2026-01-07

VERTEX PHARMACEUTICALS INC / MAVRTX

EVP, Chief Reg. & Quality Off.

Transactions

Sale
Common Stock
2026-01-07$474.99/sh−4,500$2,137,455→ 42,293 total

Footnotes (1)

[F1]Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025.

Documents

1 file

4
wk-form4_1767992722.xmlPrimary
FORM 4

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001789815

Filing Metadata

Form type: 4
Filed: Jan 8, 7:00 PM ET
Accepted: Jan 9, 4:05 PM ET
Size: 4.7 KB

View on SEC.gov